Literature DB >> 22867721

The epidemiology and risk factors for breakthrough varicella in Beijing Fengtai district.

Xue Zhang1, Yuxiang Yan, Fen Liu, Yanxia Luo, Jie Zhang, Xiaoxia Peng, Yuxiang Zhang, Shujing Han, Jianzhong Zhao, Yan He.   

Abstract

Using data from the Immunization Information System (IIS) and the Infectious Disease Reporting System (IDRS), we have described the epidemiology and analyzed the risk factors for breakthrough varicella in the Fengtai district of Beijing, China. From 2008 to 2011 the breakthrough varicella infection rate (BVR) was 0.65%, 0.85%, 1.08% and 1.56% respectively, thus demonstrating a distinct increasing tendency (P<0.001). We also compared the incidence of varicella-related illnesses between the breakthrough varicella cases and unvaccinated cases, and found that the severity of illness in the breakthrough cases was milder than that of unvaccinated cases. Moderate-to-severe cases (P=0.008, OR=0.676, 95% CI=0.505-0.904) were differently distributed in the breakthrough varicella cases and unvaccinated cases. In this study, we demonstrated that floating status (P=0.031, OR=1.96, 95% CI=1.06-3.62), contact history (P<0.001, OR=2.67, 95% CI=1.59-4.69), time since vaccination (P=0.006, OR=1.59, 95% CI=1.14-2.21), age at vaccination (P=0.010, OR=0.59, 95% CI=0.39-0.88) and combined vaccination (P=0.026, OR=3.99, 95% CI=1.18-13.54) were associated with the occurrence of breakthrough varicella, and among these, floating status is a novel risk factor. This study should provide useful information for the evaluation of the performance of varicella vaccination and prevention in PR China.
Copyright © 2012 Elsevier Ltd. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22867721     DOI: 10.1016/j.vaccine.2012.07.062

Source DB:  PubMed          Journal:  Vaccine        ISSN: 0264-410X            Impact factor:   3.641


  5 in total

1.  Clinical characteristics and risk factors associated with breakthrough varicella during varicella outbreaks.

Authors:  Wei Qin; Xiao-Kang Xu; Yao Wang; Xiang-Mei Meng; Cheng-Wu Yang; Feng Xia; Hong Su
Journal:  Hum Vaccin Immunother       Date:  2020-03-02       Impact factor: 3.452

2.  Determinants of varicella breakthrough: results of a 2012 case control study.

Authors:  Silvio Tafuri; Rocco Guerra; Maria Giovanna Cappelli; Domenico Martinelli; Rosa Prato; Cinzia Germinario
Journal:  Hum Vaccin Immunother       Date:  2014-01-07       Impact factor: 3.452

3.  Effectiveness of varicella vaccine as post-exposure prophylaxis: a meta-analysis.

Authors:  Daoyong Chen; Yue Li; Qiangsong Wu
Journal:  Hum Vaccin Immunother       Date:  2021-12-10       Impact factor: 3.452

4.  Effectiveness and failure rate of the varicella vaccine in an outbreak in Jiangsu, China: a 1:2 matched case-control study.

Authors:  Yong Wang; Lei Zhang; Xiang Sun; Yang Cao; Zhiguo Wang; Li Liu; Yan Xu; Minghao Zhou; Yuanbao Liu
Journal:  Hum Vaccin Immunother       Date:  2019-10-07       Impact factor: 3.452

5.  Pertussis Vaccination Failure in the New Zealand Pediatric Population: Study Protocol.

Authors:  Hannah Chisholm; Anna Howe; Emma Best; Helen Petousis-Harris
Journal:  Vaccines (Basel)       Date:  2019-07-16
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.